cerca CERCA
Mercoledì 19 Maggio 2021
Aggiornato: 04:31
Temi caldi

Co.

Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19 Testing

HSINCHU, May 6, 2021 /PRNewswire/ -- Brain Navi Biotechnology Co., Ltd., a brain surgery robotic company, is launching "zero-contact" medical stations in hospitals across Taiwan, fully protect medical staff and patients from the cross-infection of "highly contagious diseases." The biggest risk of infection for medical staff is during intubation, nasal swabbing, and personal protective equipment (PPE) removal, says Dr. Jerry Chen, the Brain Navi CEO. He adds that "Since the SARS crisis in Asia 17 ...

Yadea Launches Brand Globally to "Electrify Your Life"

MUNICH, April 16, 2021 /PRNewswire/ -- Leading two-wheel electric vehicle brand, Yadea Technology Group Co., Ltd. ("Yadea", 01585.HK), has kicked off the "Era of Green" with the global release of its exciting product matrix, which includes electric motorcycles, electric mopeds, electric bikes and electric kick scooters. The announcement was made during Yadea's global press conference themed "electrify your life" held on April 15, where the company also shed light on how environmentalism and low-c...

Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T

SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advisory Board. Drs. Rowinsky and Hidalgo wil...

Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies

SHANGHAI, April 6, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global biopharmaceutical company, to develop and commercialize multiple bi-specific antibodies (BsAb) based on monoclonal antibody developed by Genechem and antibodies selected by I-MAB.  

Hengtong Optic-Electric releases 400G DR4 silicon photonic transceiver, enriching 400G transceiver module product series

SUZHOU, China, March 30, 2021 /PRNewswire/ -- On March 26th 2021, Hengtong Optic-Electric Co., Ltd. convened a new product launch. Its subsidiary, Hengtong Rockley Technology Co., Ltd. moved forward to enrich its high-speed transceiver modules for data communication. The mass production version of 400G QSFP-DD DR4 transceiver based on silicon photonic circuits and 400G QSFP-DD FR4 transceiver based on traditional free space solution were released, making Hengtong capable of providing customers wi...

Newly Released Antiviral Fabric from SQ Group Kills COVID-19 Virus

JINAN, China, Feb. 10, 2021 /PRNewswire/ -- Jinan Shengquan Group Share Holding Co., Ltd. (SQ Group) in collaboration with Hong Kong Nano and Advanced Materials Institute (NAMI) released its latest scientific research result, a newly unveiled antiviral, antibacterial fabric.

Zamst annuncia la sponsorizzazione del pallavolista professionista Yuji Nishida

TOKYO, 8 febbraio 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., proprietaria di Zamst, marchio di tutori e altri articoli sanitari per atleti con sede a Tokyo, in Giappone, ha stipulato un accordo di sponsorizzazione sportiva con Yuji Nishida, giocatore professionista della JTEKT Stings, squadra di pallavolo maschile militante nella V.League.

Zoomlion Celebrates Maiden Assembly of Intelligent Excavator in Zoomlion Smart Industrial City

CHANGSHA, China, Jan. 6, 2021 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. (Zoomlion) has achieved a major breakthrough in the intelligent manufacturing of large-tonnage excavators as the first excavator rolled off the assembly line on December 31, 2020 in the first constructed Intelligent Excavator Manufacturing Park (the "Park") in Zoomlion Smart Industrial City (the "City") in Changsha, Hunan Province.

Zoomlion Researcher Yu Lekang Wins China's Top National Employee Award

BEIJING, Dec 18, 2020 /PRNewswire/ -- Yu Lekang, Deputy General Manager and researcher of construction machinery manufacturer Zoomlion Heavy Industry Science & Technology Co., Ltd. (01157.HK), was awarded China's most prestigious employee award, the National Model Worker, at the National Labor Model and Advanced Workers Commendation Meeting in Beijing.

Drawbridge Health Announces Partnerships to Fuel Expansion in Japan

MENLO PARK, California, Oct. 27, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as well as a new research and development collaboration agreement.  Drawbridge Health also reported that it has secured a strategic investment from new investor TOHO HOLDINGS CO., LTD. ("TOHO HOLDINGS"), in ...

Risen Capitalises on Future Market Trend with a 1.5 GW Global Order

NINGBO, China, Oct. 14, 2020 /PRNewswire/ -- Risen Energy Co., Ltd, a leading, Tier 1 manufacturer of high-performance solar photovoltaic products, today disclosed the signing of a contract for 1.5 GW of its Bifacial Mono PERC Solar PV modules, in cooperation with a well-known, independent, global power producer.

Nippon Express mette a disposizione reti globali per la fornitura sicura e affidabile di prodotti farmaceutici nel mondo

TOKYO, 14 settembre 2020 /PRNewswire/ -- Nippon Express Co., Ltd. sta sviluppando reti di fornitura di prodotti farmaceutici conformi ai requisiti software e hardware delle buone prassi di distribuzione (norme volte a garantire la corretta distribuzione di prodotti farmaceutici, di seguito "norme GDP"), al fine di consentire una fornitura più sicura e affidabile dei prodotti farmaceutici.

Y.S.S. spinge avanti con un più aggressivo piano di espansione del business ed enfatizza la sua performance come leader globale negli ammortizzatori

BANGKOK, 8 settembre 2020 /PRNewswire/ -- Y.S.S. (Thailand) Co., Ltd, produttore e sviluppatore thailandese di ammortizzatori, pone l'accento sulla sua posizione di numero uno mondiale negli ammortizzatori ad alta prestazione. L'azienda si muove anche più rapidamente nella sua espansione di business in ogni regione, con l'ambizione di diventare il numero uno mondiale degli ammortizzatori ad alta perfomance della Thailandia nei prossimi tre anni.

Kokam lancia un nuovo sistema di batterie per il mercato globale dei gruppi di continuità

SEUL, Corea del Sud, 31 agosto 2020 /PRNewswire/ -- Kokam Co., Ltd, società controllata di SolarEdge e fornitore di batterie agli ioni di litio e soluzioni energetiche integrate, ha annunciato oggi il lancio di un nuovo sistema di batterie, avanzato e dal valido rapporto qualità-prezzo, destinato ai gruppi di continuità (Uninterruptible Power System, UPS). Kokam sta consolidando sempre più la propria posizione sul mercato UPS e, in questa prospettiva, ha sviluppato un nuovo sistema di batterie ba...

Risen Strikes 165MW with Sprng Energy

NINGBO, China, Aug. 26, 2020 /PRNewswire/ -- Risen Energy Co., Ltd, a leading, Tier 1 manufacturer of high-performance solar photovoltaic products, has recently announced an additional contract for the supply of 165MW of customised high-performance solar PV modules with Sprng Energy.

Gan & Lee Pharmaceuticals Initiates First-in Human Phase 1 Clinical Trial for New Anti-tumor Drug GLR2007

BEIJING, China and BRIDGEWATER, New Jersey, July 30, 2020 /PRNewswire/ -- Today marks a major milestone for Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), with the initiation of our first-in-human Phase 1 clinical trial for GLR2007, our internally-invented, cyclin-dependent kinase 4/6 (CDK4/6) inhibitor as a potential therapy for advanced solid tumors. CDK4/6 activity is central to cell cycle regulation and has a key role in the occurrence and p...

ora in
Prima pagina
articoli
in Evidenza